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Background: Recurrent respiratory papillomatosis is a benign neoplastic disease of viral 
aetiology which can have significant morbidity or mortality and presents great challenges in it 
management. This study evaluates our experience with the management of this disease. 
Methods: This was a 10 year retrospective review of 29 patients with histologically confirmed 
recurrent respiratory papillomatosis managed in the Jos University Teaching Hospital, Jos, 
Nigeria. 
Results: Twenty nine patients aged between 2 months and 45 years were studied. There were 
21(72.4%) males and 8 (27.6%) females. The highest incidence (62.1%) was in children less 
than 10 years.The presenting features were hoarseness in all patients and dyspnea in 28 (96.6%) 
patients who had emergency tracheostomy. Twenty five (89.3%) patients were decannulated 
within 1 week. No patient had distal viral spread. Twenty three (79.3%) patients presented 
within 10 months of onset of symptoms and 6 (20.7%) patients after this period.All the patients 
had endoscopic surgical excision. The commonest site of lesions was the vocal cords in 16 
(55.2%) patients and the anterior commissure in 13 (44.8%) patients. Recurrence occurred in 2 
(6.9%) patients. No malignant transformation occurred. 
Conclusion: Conventional endoscopic surgical excision is safe and tracheostomy when needed 




Recurrent respiratory papillomatosis is a benign neoplastic disease characterized by warty-like 
lesions occurring anywhere along the aerodigestive tract and caused by the Human Papilloma 
virus (HPV) of which 90 subtypes has been described1. HPV types 6  and 11 are responsible for 
papilloma in the airway2. Two clinical forms of the disease occur, the juvenile-onset recurrent 
respiratory papillomatosis (JORRP), an aggressive form and the adult-onset recurrent respiratory 
papillomatosis (AORRP), which is less aggressive, the former being commoner3. It is a 
potentially devastating disease exhibiting high recurrence and can have significant morbidity 
presenting with hoarseness or result in mortality due to airway compromise or less commonly 
malignant transformation4- recurrent respiratory papillomatosis is an acknowledged risk factor 
for pulmonary squamous cell carcinoma5. 
 
Surgical debulking is the foundation of treatment with endoscopic laser surgery being the 
current mainstay of treatment6. However, newer surgical techniques utilizing powered 
microdebriders are taking the place of carbon-dioxide laser ablation7. Research studies are on-
going investigating adjuvant medical therapies such as oral indole-3-carbinol8, intralesional 
cidofovir injections9 and lymphoblastoid interferon10 amongst others. No safe adjuvant therapy 
is currently available7.  
 
Tracheostomy in the management of recurrent respiratory papillomatosis is controversial, with 
advocates11 and those who recommend its avoidance if possible as distal viral spread to 
uninvolved respiratory mucosa could occur12. This group also suggests early decannulation if 
tracheostomy is unavoidable. Iatrogenic airway stenosis, posterior glottic stenosis13 and glottic 
webs14 may also occur post-operatively. We present the clinical presentation findings, 
management and outcome of patients with recurrent respiratory papillomatosis treated over a 10 
year period in the Jos University Teaching Hospital, Jos, Nigeria. 
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Patients and Methods 
 
Following approval from the Ethical Clearance Committee of our institution, the medical 
records of consecutive patients presenting to our hospital with recurrent respiratory papilloma 
within the period August 1997 to July 2007 was analyzed for age, sex, clinical presentation, 
management profile and outcome of treatment. The results are presented in simple descriptive 




Twenty nine patients aged between 2 months and 45 years were managed for respiratory 
papilloma within the study period. There were 21(72.4%) males and 8 (27.6%) females, giving a 
male: female ratio of 2.6:1. The highest incidence (62.1%) of this disease was seen in children 
less than 10 years of age (Table 1). All the patients had histological confirmation of recurrent 
respiratory papilloma. The presenting features were hoarseness in all the patients and dyspnea in 
28 (96.6%) of the cases. Twenty three (79.3%) patients presented within 10 months of onset of 
symptoms and 6 (20.7%) patients after this period. 
 
All but one patient, a 37 year old male, had emergency tracheostomy. Twenty five (89.3%) of 
these patients were decannulated within 1 week of insertion of tracheostomy tubes, 2 (7.1%) 
patients within 2 weeks and 1 (3.6%) patient within 3 weeks (Table 2). No patient had evidence 
of distal viral spread to uninvolved respiratory mucosa. All the patients had direct laryngoscopy 
and clearance with relief of symptoms. The commonest site of lesions was the vocal cords in 16 
(55.2%) patients and the anterior commissure in 13 (44.8%) patients. Follow-up revealed 
recurrence in two patients who had one repeated episode of direct laryngoscopy and clearance 
each, giving a recurrence rate of 6.9%. There was no case of post-operative airway stenosis, 




Recurrent respiratory papillomatosis is a potentially devastating benign neoplastic disease of 
viral etiology which can have significant morbidity or result in mortality and present great 
challenges in its management. 
 
Table1. Age Distribution of Patients with Recurrent Respiratory Papillomatosis 
 
       Age group (years)               Frequency                              Percentage 
          0-10                                       18                                             62.1 
          11-20                                      4                                              13.8 
          21-30                                      4                                              13.8 
          31-40                                      2                                               6.9 
          41-50                                      1                                               3.4 
          Total                                      29                                             100  
 
Table 2. Duration Before Decannulation 
 
      Duration                                 Frequency                          Percentage 
      Within 1week                             25                                       89.3 
      Within 2weeks                             2                                         7.1 
      Within 3weeks                            1                                         3.6 
      Total                                           28                                       100 
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The presenting features are usually that of hoarseness and airway compromise necessitating an 
emergency tracheostomy. In this series, all the patients presented with hoarseness and 28 
(96.6%) patients with dyspnea necessitating emergency tracheostomy. However, no case of 
distal viral spread to uninvolved respiratory mucosa was recorded despite prolonged intubations 
in some patients. 
 
Like in a previous study in Ibadan, Nigeria15 the incidence of this disease is higher in the under 
10 age group. Our study still reports the vocal cords and the anterior commissure as the 
commonest sites of recurrent respiratory papillomatosis.We recorded a relatively low recurrence 
rate of 6.9% compared to other documented studies4,15. Post-operative complications such as 
airway stenosis13 and glottic webs14 may occur. Our study reports no case of complications 
following surgery and there was no malignant transformation recorded. 
 
Though endoscopic laser surgery remains the mainstay of treatment of recurrent respiratory 
papillomatosis, our study shows that in the absence of such a facility e.g. in health institutions of 
developing countries like Nigeria, the conventional endoscopic surgical excision of this lesion 
can be done with minimal or no complications and that tracheostomy when needed  
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